J. Prieto

1.3k total citations
79 papers, 1.0k citations indexed

About

J. Prieto is a scholar working on Epidemiology, Pharmacology and Infectious Diseases. According to data from OpenAlex, J. Prieto has authored 79 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Epidemiology, 40 papers in Pharmacology and 29 papers in Infectious Diseases. Recurrent topics in J. Prieto's work include Antibiotics Pharmacokinetics and Efficacy (38 papers), Pneumonia and Respiratory Infections (30 papers) and Antibiotic Resistance in Bacteria (29 papers). J. Prieto is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (38 papers), Pneumonia and Respiratory Infections (30 papers) and Antibiotic Resistance in Bacteria (29 papers). J. Prieto collaborates with scholars based in Spain, United States and United Kingdom. J. Prieto's co-authors include María-José Giménez, Luís Alou, Lorenzo Aguilar, David Sevillano, Fabio Cafini, Natalia González, José Barberán, L. Aguilar, Marı́a Luisa Gómez-Lus and David Martı́nez and has published in prestigious journals such as PLoS ONE, The American Journal of Medicine and Antimicrobial Agents and Chemotherapy.

In The Last Decade

J. Prieto

76 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Prieto Spain	18	483	397	318	300	167	79	1.0k
M L van Ogtrop Netherlands	14	274 0.6×	381 1.0×	341 1.1×	335 1.1×	114 0.7×	20	981
Pamela R. Tessier United States	19	648 1.3×	675 1.7×	290 0.9×	511 1.7×	76 0.5×	41	1.1k
Ómar Vesga Colombia	17	272 0.6×	529 1.3×	432 1.4×	356 1.2×	115 0.7×	34	1.3k
Rupali Jain United States	17	419 0.9×	322 0.8×	412 1.3×	335 1.1×	76 0.5×	55	1.1k
Nancy M. Laing Canada	15	718 1.5×	246 0.6×	261 0.8×	446 1.5×	73 0.4×	20	1.2k
Maria Teresa Mascellino Italy	20	283 0.6×	187 0.5×	328 1.0×	241 0.8×	189 1.1×	75	1.2k
Kim Credito United States	16	318 0.7×	308 0.8×	410 1.3×	255 0.8×	55 0.3×	27	776
Scott A. Van Wart United States	19	324 0.7×	548 1.4×	349 1.1×	353 1.2×	70 0.4×	33	901
Laurent Massias France	26	567 1.2×	562 1.4×	588 1.8×	534 1.8×	279 1.7×	71	1.8k
Marie-Dominique Kitzis France	19	523 1.1×	683 1.7×	411 1.3×	799 2.7×	129 0.8×	48	1.5k

Countries citing papers authored by J. Prieto

Since Specialization

Citations

This map shows the geographic impact of J. Prieto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Prieto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Prieto more than expected).

Fields of papers citing papers by J. Prieto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Prieto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Prieto. The network helps show where J. Prieto may publish in the future.

Co-authorship network of co-authors of J. Prieto

This figure shows the co-authorship network connecting the top 25 collaborators of J. Prieto. A scholar is included among the top collaborators of J. Prieto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Prieto. J. Prieto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alou, Luís, et al.. (2017). [Is it necessary to prescribe antibiotics in impacted third molar surgical removal?: comparative study between prescribing patterns].. PubMed. 30(1). 34–39. 2 indexed citations

Alou, Luís, et al.. (2017). ¿Está indicada la prescripción de antibióticos en la extracción del tercer molar retenido?: Estudio comparativo entre patrones de prescripción. Revista española de quimioterapia. Suplemento. 30(1). 34–39. 2 indexed citations

González, Natalia, David Sevillano, Luís Alou, et al.. (2013). Influence of the MBC/MIC ratio on the antibacterial activity of vancomycin versus linezolid against methicillin-resistant Staphylococcus aureus isolates in a pharmacodynamic model simulating serum and soft tissue interstitial fluid concentrations reported in diabetic patients. Journal of Antimicrobial Chemotherapy. 68(10). 2291–5. 34 indexed citations

Corcuera, María Teresa, et al.. (2013). Morphological plasticity of Streptococcus oralis isolates for biofilm production, invasiveness, and architectural patterns. Archives of Oral Biology. 58(11). 1584–1593. 5 indexed citations

Giménez, María-José, Natalia González, Luís Alou, et al.. (2009). Bactericidal activity of daptomycin versus vancomycin in the presence of human albumin against vancomycin-susceptible but tolerant methicillin-resistant Staphylococcus aureus (MRSA) with daptomycin minimum inhibitory concentrations of 1–2μg/mL. International Journal of Antimicrobial Agents. 35(2). 131–137. 10 indexed citations

Sevillano, David, L. Aguilar, Luís Alou, et al.. (2008). β-Lactam Activity against Penicillin-Resistant <i>Streptococcus pneumoniae</i> Strains Exhibiting Higher Amoxicillin versus Penicillin Minimum Inhibitory Concentration Values: An in vitro Pharmacodynamic Simulation. Chemotherapy. 54(2). 84–90. 5 indexed citations

Cafini, Fabio, L. Aguilar, Luís Alou, et al.. (2008). Cidal activity of oral third-generation cephalosporins against Streptococcus pneumoniae in relation to cefotaxime intrinsic activity. European Journal of Clinical Microbiology & Infectious Diseases. 27(8). 679–683. 8 indexed citations

Alou, Luís, Lorenzo Aguilar, David Sevillano, et al.. (2006). Urine bactericidal activity against resistant Escherichia coli in an in vitro pharmacodynamic model simulating urine concentrations obtained after 2000/125 mg sustained-release co-amoxiclav and 400 mg norfloxacin administration. Journal of Antimicrobial Chemotherapy. 57(4). 714–719. 7 indexed citations

Alou, Luís, et al.. (2005). Is there a pharmacodynamic need for the use of continuous versus intermittent infusion with ceftazidime against Pseudomonas aeruginosa? An in vitro pharmacodynamic model. Journal of Antimicrobial Chemotherapy. 55(2). 209–213. 53 indexed citations

10.

Alou, Luís, Lorenzo Aguilar, David Sevillano, et al.. (2005). Effect of opsonophagocytosis mediated by specific antibodies on the co-amoxiclav serum bactericidal activity against Streptococcus pneumoniae after administration of a single oral dose of pharmacokinetically enhanced 2000/125 mg co-amoxiclav to healthy volunteers. Journal of Antimicrobial Chemotherapy. 55(5). 742–747. 4 indexed citations

11.

Sevillano, David, María-José Giménez, Luís Alou, et al.. (2004). Bactericidal activity of amoxicillin against non-susceptible Streptococcus pneumoniae in an in vitro pharmacodynamic model simulating the concentrations obtained with the 2000/125 mg sustained-release co-amoxiclav formulation. Journal of Antimicrobial Chemotherapy. 54(6). 1148–1151. 21 indexed citations

12.

Alou, Luís, et al.. (2004). In vitro activity of mupirocin and amoxicillin-clavulanate alone and in combination against staphylococci including those resistant to methicillin. International Journal of Antimicrobial Agents. 23(5). 513–516. 16 indexed citations

13.

Sevillano, David, et al.. (2001). [Activity of different antimicrobial agents against penicillin-resistant Streptococcus pneumoniae].. PubMed. 14(4). 345–50. 3 indexed citations

14.

Ruíz, Guadalupe, et al.. (2001). Concentraciones plasmáticas de fibronectina como marcador de evolución en pacientes sépticos. Enfermedades Infecciosas y Microbiología Clínica. 19(3). 93–98. 2 indexed citations

15.

Prieto, J., et al.. (1999). Does the Degree of Penicillin Susceptibility ofStreptococcus pneumoniaeAffect the Bactericidal Activity of Co-Amoxiclav Versus Oral Cephalosporins at Physiological Concentrations? AnIn VitroPharmacodynamic Simulation. Journal of Chemotherapy. 11(5). 345–348. 4 indexed citations

16.

Gómez-Lus, Marı́a Luisa, et al.. (1998). Effect of polymorphonuclear neutrophils on serum bactericidal activity againstStreptococcus pneumoniae after amoxicillin administration. European Journal of Clinical Microbiology & Infectious Diseases. 17(1). 40–43. 10 indexed citations

17.

Prieto, J., et al.. (1997). Effects of Antifungal Pretreatment on the Susceptibility of <i>Candida albicans</i> to Human Leukocytes. Chemotherapy. 43(5). 346–351. 5 indexed citations

18.

Gómez-Lus, Marı́a Luisa, et al.. (1997). Effect of clavulanic acid and/or polymorphonuclear neutrophils on amoxicillin bactericidal activity againstStreptococcus pneumoniae. European Journal of Clinical Microbiology & Infectious Diseases. 16(7). 512–516. 16 indexed citations

19.

Fuentes, Fernando, et al.. (1995). In Vivo and in Vitro Study of Several Pharmacodynamic Effects of Meropenem. Scandinavian Journal of Infectious Diseases. 27(5). 469–474. 17 indexed citations

20.

Prieto, J., et al.. (1991). Postantibiotic Effect of Ciprofloxacin Compared with that of Five Other Quinolones. Chemotherapy. 37(6). 420–425. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact